Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice

Archives of Dermatological Research

Volumn 303, Issue 9, 2011, Pages 659-667

  Funakushi, Naoko ^a   Yamaguchi, Takuji ^a,d   Jiang, Ju ^a,b   Imamura, Sachiko ^d   Kuhara, Takatoshi ^b   Suto, Hajime ^a,b   Ueki, Rie ^c   Kase, Yoshio ^d   Kobayashi, Hiroyuki ^a   Ogawa, Hideoki ^a,b   Ikeda, Shigaku ^a,b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

^d Tsumura Research Laboratories   (Japan)

Author keywords

Atopic dermatitis; GLT 1; NC Nga mice; NMDA receptor; Scratching behavior; Yokukansan

Indexed keywords

ANGELICA ROOT EXTRACT; ATRACTYLODES EXTRACT; BUPLEURUM ROOT EXTRACT; CNIDIUM RHIZOME EXTRACT; FEXOFENADINE; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; UNCARIA TOMENTOSA EXTRACT; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; YOKUKANSAN;

ANGELICA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; ATRACTYLODES; BEHAVIOR DISORDER; BUPLEURUM; CNIDIUM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLYCYRRHIZA; GROOMING; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCRATCHING; SKIN DEFECT; SKIN WATER LOSS; UNCARIA;

ANIMALS; ANTI-ANXIETY AGENTS; DERMATITIS, ATOPIC; DRUGS, CHINESE HERBAL; EXCITATORY AMINO ACID TRANSPORTER 2; GENE EXPRESSION REGULATION; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; IMMUNOHISTOCHEMISTRY; MALE; MEDICINE, KAMPO; MICE; MICE, INBRED STRAINS; RECEPTORS, N-METHYL-D-ASPARTATE; SEX FACTORS; SIGNAL TRANSDUCTION; SKIN; SOCIAL ISOLATION; TERFENADINE;

EID: 80755140665     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-011-1137-9     Document Type: Article

References (36)

1. JM Hanifin G Rajka 1980 Diagnostic features of atopic dermatitis Acta Derm Venereol (Stockh) 92 Suppl 44 47
2. H Saeki M Furue F Furukawa, et al. 2009 Guidelines for management of atopic dermatitis J Dermatol 36 10 563 577 19785716 10.1111/j.1346-8138.2009. 00706.x
3. H Suto H Matsuda K Mitsuishi, et al. 1999 NC/Nga mice: a mouse model for atopic dermatitis Int Arch Allergy Immunol 120 suppl 1 70 75 10529609 10.1159/000053599 (Pubitemid 29457367)
4. J Jiang T Kuhara R Ueki, et al. 2007 Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC/Nga mice J Dermatol Sci 47 244 247 17604608 10.1016/j.jdermsci.2007.05.006 1:CAS:528: DC%2BD2sXotVCntb0%3D (Pubitemid 47077898)
5. H Kobayashi M Ishii S Takeuchi, et al. 2008 Efficacy and safety of a traditional herbal medicine, hochu-ekki-to in the long-term management of kikyo (delicate constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study Evid Based Complement Alternat Med 7 3 8367 8373
6. XK Gao K Fuseda T Shibata, et al. 2005 Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice Evid Based Complement Alternat Med 2 2 191 199 15937560 10.1093/ecam/neh077 (Pubitemid 41399492)
7. K Iwasaki T Satoh-Nakagawa M Maruyama, et al. 2005 A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients J Clin Psychiatry 66 2 248 252 15705012 10.4088/JCP.v66n0214 (Pubitemid 40314333)
8. K Iwasaki M Maruyama N Tomita, et al. 2005 Effects of the traditional Chinese herbal medicine Ti-Gan San for cholinesterase inhibitor-resistant visual neuropsychiatric symptoms in patients with dementia with Lewy bodies J Clin Psychiatry 66 12 1612 1613 16401166 10.4088/JCP.v66n1219a (Pubitemid 43068707)
9. T Kawanabe A Yoritaka H Shimura, et al. 2010 Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia Prog Neuro Psychopharmacol Biol Psychiatry 34 2 284 287 10.1016/j.pnpbp.2009.11. 019
10. T Miyaoka M Furuya H Yasuda, et al. 2009 Yi-Gan san as adjunctive therapy for treatment-resistant schizophrenia: open-label study Clin Neurophamacol 32 1 6 9 10.1097/WNF.0b013e31817e08c3 1:CAS:528:DC%2BD1MXit1CjsLY%3D
11. Y Nakamura K Tajima I Kawagoe, et al. 2009 Efficacy of traditional herbal medicine Yokukansan on patients with neuropathic pain Masui 58 10 1248 1255 19860227
12. K Okahara Y Ishida Y Hayashi, et al. 2010 Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease Prog Neuropsychopharmacol Biol Psychiatry 34 3 532 536 20170698 10.1016/j.pnpbp.2010.02.013 1:CAS:528:DC%2BC3cXjs1ajsb8%3D
13. T Satoh T Takahashi K Iwasaki, et al. 2009 Traditional Chinese medicine on four patients with Hunchington's disease Mov Disord 24 3 453 455 19133663 10.1002/mds.22447
14. H Shinno M Yamanaka I Ishikawa, et al. 2010 Successful treatment of restless legs syndrome with herbal prescription Yokukansan Prog Neuro Psychopharmacol Biol Psychiatry 34 1 252 253 10.1016/j.pnpbp.2009.11.007
15. J Jiang T Yamaguchi N Funakushi, et al. 2009 Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice J Dermatol Sci 56 1 37 42 19647983 10.1016/j.jdermsci.2009. 07.003 1:CAS:528:DC%2BD1MXhtVKlsrrE
16. A Takaoka I Arai M Sugimoto, et al. 2006 Involvement of IL-31 on scratching behavior on NC/Nga mice with atopic-like dermatitis Exp Dermatol 15 161 167 16480423 10.1111/j.1600-0625.2006.00405.x 1:CAS:528:DC%2BD28Xjt12msLs%3D
17. J Feusner E Hembacher KA Phillips 2009 The mouse who couldn't stop washing: pathologic grooming in animals and humans CNS Spectr 14 9 503 513 19890232
18. MA Gupts AK Gupta 2003 Psychiatric and psychological co-morbidity in patients with dermatologic disorders Am J Clin Dermatol 4 12 833 842 10.2165/00128071-200304120-00003 (Pubitemid 38030859)
19. JM Welch J Lu RM Rodriguiz, et al. 2007 Cortico-striatal synaptic defects and OCD-like behaviors in SAPAP3 mutant mice Nature 448 7156 894 900 17713528 10.1038/nature06104 1:CAS:528:DC%2BD2sXptlWjsL0%3D (Pubitemid 47312780)
20. K Terawaki Y Ikarashi K Sekiguchi, et al. 2010 Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells J Ethnopharmacol 127 2 306 312 19913081 10.1016/j.jep.2009.11.003
21. N Egashira K Iwasaki A Ishibashi, et al. 2008 Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT) 2A receptors in the prefrontal cortex Prog Neuropsychopharmacol Biol Psychiatry 32 6 1516 1520 18558456 10.1016/j.pnpbp.2008.05.010 1:CAS:528:DC%2BD1cXptVeqsL0%3D
22. 1a receptor agonist in atopic dermatitis Clin Exp Dermatol 35 835 840 20089082 10.1111/j.1365-2230. 2009.03771.x 1:STN:280:DC%2BC3cbltVOkug%3D%3D
23. Z Kawakami H Kanno T Ueki, et al. 2009 Neuroprotective effects of Yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxity in cultured cells Neuroscience 159 4 1397 1407 19409210 10.1016/j.neuroscience. 2009.02.004 1:CAS:528:DC%2BD1MXktFektr4%3D
24. Z Kawakami Y Ikarashi Y Kase 2010 Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan ameliorate thiamine deficiency-induces dysfunction of glutamate transport in cultured rat cortical astrocytes Eur J Pharmacol 626 2-3 154 158 19818347 10.1016/j.ejphar.2009.09.046 1:CAS:528:DC%2BD1MXhsV2mtLrK
25. Y Ikarashi S Iizuka S Imamura, et al. 2009 Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats Biol Pharm Bull 32 10 1701 1709 19801831 10.1248/bpb.32.1701 1:CAS:528:DC%2BD1MXhsVKitr3O
26. T Hiratsuka S Matsuzaki S Miyata, et al. 2010 Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response PLoS One 5 10 e13280 20967273 10.1371/journal.pone.0013280
27. N Uchida N Egashira K Iwasaki, et al. 2009 Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents Biol Pharm Bull 32 3 372 375 19252280 10.1248/bpb.32.372 1:CAS:528:DC%2BD1MXmsVait7o%3D
28. AR Doo SN Kim JY Park, et al. 2010 Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo J Ethnopharmacol 131 2 433 442 20633628 10.1016/j.jep.2010.07.008
29. RM Karlsson K Tanaka M Heilig, et al. 2008 Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist Biol Psychiatry 64 9 810 814 18550032 10.1016/j.biopsych.2008.05.001 1:CAS:528:DC%2BD1cXht1eisbbK
30. P Genever S Maxfield G Kennovin, et al. 1999 Evidence for a novel glutamate-mediated signaling pathway in keratinocytes J Invest Dermatol 112 337 342 10084312 10.1046/j.1523-1747.1999.00509.x 1:CAS:528:DyaK1MXhs12msrk%3D (Pubitemid 29125111)
31. T Skerry P Genever 2001 Glutamate signaling in non-neuronal tissues Trends Pharmacol Sci 22 4 174 181 11282417 10.1016/S0165-6147(00)01642-4 1:CAS:528:DC%2BD3MXit1Wnsbg%3D (Pubitemid 32244303)
32. MC Lagerström K Rogoz B Abrahamsen, et al. 2010 VGLUT2-dependent sensory neurons in the TRPV1 population regulate pain and itch Neuron 68 3 529 542 21040852 10.1016/j.neuron.2010.09.016
33. M Fischer D Glanz T William, et al. 2004 N-methyl-d-aspartate receptors influence the intracellular calcium concentration of keratinocytes Exp Dermatol 13 8 512 519 15265016 10.1111/j.0906-6705.2004.00200.x 1:CAS:528: DC%2BD2cXntlOkuro%3D (Pubitemid 39144552)
34. S Fuziwara K Inoue M Denda 2002 NMDA-type glutamate receptor is associated with cutaneous barrier homeostasis J Invest Dermatol 120 6 1023 1029 10.1046/j.1523-1747.2003.12238.x (Pubitemid 36702913)
35. VB Morhenn M Murakami T O'Grady, et al. 2004 Characterization of the expression and function of N-methyl-d-aspartate receptor in keratinocytes Exp Dermatol 13 8 505 511 15265015 10.1111/j.0906-6705.2004.00186.x 1:CAS:528:DC%2BD2cXntlOkurw%3D (Pubitemid 39144551)
36. WK Nahm BD Philpot MM Adams, et al. 2004 Significance of N-methyl-d-aspartate (NMDA) receptor-mediated signaling in human keratinocytes J Cell Physiol 200 2 309 317 15174101 10.1002/jcp.20010 1:CAS:528: DC%2BD2cXlslaqu7w%3D (Pubitemid 38880214)